Average Co-Inventor Count = 2.04
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Euro-Celtique S.a. (9 from 270 patents)
2. Rhodes Pharmaceuticals L.p. (5 from 10 patents)
3. Purdue Pharma L.p. (4 from 545 patents)
18 patents:
1. 10463624 - Controlled release formulations
2. 10258616 - Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
3. 10039719 - Methods of treating attention deficit hyperactivity disorder
4. 10022330 - Methods of preparing oral controlled release formulations
5. 9949931 - Methods of treating attention deficit hyperactivity disorder
6. 9814710 - Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
7. 9801823 - Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
8. 9700508 - Pharmaceutical compositions comprising hydromorphone and naloxone
9. 9066869 - Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
10. 8580310 - Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
11. 7438930 - Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
12. 7247318 - Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
13. 7083808 - Controlled/modified release oral methylphenidate formulations
14. 6673367 - Controlled/modified release oral methylphenidate formulations
15. 6419960 - Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations